Division of molecular medicine, Bose Institute, P-1/12, CIT Scheme VII M, Calcutta, West Bengal, India.
Free Radic Res. 2012 Mar;46(3):240-52. doi: 10.3109/10715762.2011.650694. Epub 2012 Jan 23.
The present study investigated the role of D-saccharic acid 1,4-lactone (DSL) in the spleen tissue of alloxan (ALX) induced diabetic rats. Diabetes was induced in rats by injecting ALX (at a dose of 120 mg/kg body weight) intraperitoneally in sterile normal saline. Elevated levels of blood glucose, glycosylated Hb and TNFα decreased levels of plasma insulin and disturbed intra-cellular antioxidant machineries were detected in ALX exposed animals. Oral administration of DSL at a dose of 80 mg/kg body weight, however, restored these alterations in diabetic rats. Studies on the mechanism of ALX-induced diabetes showed that hyperglycemia caused disruption of mitochondrial membrane potential in the spleen, released cytochrome C in the cytosol, activated caspase 3 and ultimately led to apoptotic cell death. Results suggest that DSL possesses the ability of protecting the spleen tissue from ALX-induced hyperglycemia and thus could act as an anti-diabetic agent in lessening diabetes associated spleen dysfunction.
本研究探讨了 D-阿拉伯糖酸-1,4-内酯(DSL)在四氧嘧啶(ALX)诱导的糖尿病大鼠脾脏组织中的作用。通过在无菌生理盐水中介导腹腔内注射 ALX(剂量为 120mg/kg 体重),在大鼠中诱导糖尿病。在 ALX 暴露的动物中,检测到血糖、糖化 Hb 和 TNFα 水平升高,血浆胰岛素水平降低,细胞内抗氧化机制受到干扰。然而,以 80mg/kg 体重的剂量口服给予 DSL,可使糖尿病大鼠的这些改变得到恢复。对 ALX 诱导的糖尿病的机制研究表明,高血糖导致脾脏线粒体膜电位破坏,细胞色素 C 释放到胞浆中,激活半胱氨酸蛋白酶 3,最终导致细胞凋亡死亡。结果表明,DSL 具有保护脾脏组织免受 ALX 诱导的高血糖的能力,因此可作为一种抗糖尿病药物,减轻与糖尿病相关的脾脏功能障碍。